MedPath

Sleep in addiction care

Completed
Conditions
Insomnia in patients with substance use disorder
Mental and Behavioural Disorders
Nonorganic sleep disorders
Registration Number
ISRCTN59953554
Lead Sponsor
Mental Health Group in North and Middle Limburg (GGZ Noord- en Midden-Limburg) (Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
90
Inclusion Criteria

1. Both males and females, age limit: 65
2. Patients who are admitted for at least 5 weeks to an addiction clinic
3. Those who are clean i.e. addicted patients that do not use drugs/alcohol anymore
4. Score of 5 or higher in the Pittsburgh Sleep Quality Index (PSQI)

Exclusion Criteria

1. Patients with sleep problems other than problems of initiating or maintaining sleep
2. Diagnosis of severe depression, attention deficit hyperactivity disorder (ADHD)
3. Patients who have a primary benzodiazepine addiction

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Subjective sleep efficiency as measured by a sleep log. The sleep log will be recorded by the participants during the 6-week treatment period. The sleep log has several outcome measures: time in bed (TIB), total sleep time (TST), sleep onset latency (SOL), sleep efficiency (SE), wake after sleep onset (WASO) and number of awakenings (AWAK). <br>2. Sleep quality measured by the Pittsburgh Sleep Quality Index (PSQI) at timepoints T0, T1, T2, T3 and T4<br><br>Timepoints:<br>T0 = Day of clinical intake<br>T1 = 4th week of treatment<br>T2 = 6th week of treatment, before randomisation<br>T3 = At the end of sleep training<br>T4 = 2 months after the sleep training
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath